Articoli correlati a HER2 and Cancer: Mechanism, Testing and Targeted Therapy

HER2 and Cancer: Mechanism, Testing and Targeted Therapy - Rilegato

 
9781611226508: HER2 and Cancer: Mechanism, Testing and Targeted Therapy
Rilegato
ISBN 10: 1611226503 ISBN 13: 9781611226508
Casa editrice: Nova Science Pub Inc, 2011

Sinossi

The HER2 receptor is a 185-kDa transmembrane glycoprotein with tyrosine kinase activity, and belongs in the human epidermal growth factor receptor (HER) family consisting of four members. Moreover, aberrant HER2 protein overexpression has been linked to various human gynecological adenocarcinomas, including breast, endometrium, ovary and cervix, and has been found to be a poor prognostic factor for survival. This new book presents topical research in the study of HER2, including targeting HER2 with photodynamic therapy; HER2 shedding as a biomarker in breast cancer; development of trastuzumab resistance and targeted nanomedicines conjugated with HER2 antibodies in cancer therapy.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Editore
Nova Science Pub Inc
Data di pubblicazione
2011
Lingua
Inglese
ISBN 10 
1611226503
ISBN 13 
9781611226508
Rilegatura
Copertina rigida
Numero edizione
1
Numero di pagine
245
Redattore
Williams Sophie I., Rogers Christopher E.
Contatto del produttore
non disponibile
Persona responsabile
Easy Access System Europe Oü, 16879218
gpsr.requests@easproject.com

Mustamäe tee 50, 10621, Tallinn, Estonia
Tallinn
Estonia